9 Results for "

lower urinary tract symptoms

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "lower urinary tract symptoms" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-10122
CAS No.: 160970-54-7
Purity:  99.82%
Synonyms: KAD 3213; KMD 3213
Research Areas:  

Endocrinology Cancer

Silodosin (KAD 3213; KMD 3213) is a potent, selective and orally active α1A-adrenergic receptor (α1A-AR) blocker. Silodosin exhibits high affinity for α1A-AR (Ki=0.036 nM), over 162-fold and 50-fold than for α1B-AR and α1D-AR with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent, it can be used for the investigation of LUTS/BPH .
loading...
    loading...
Cat. No.: HY-P3501
CAS No.: 492447-54-8
Synonyms: NX-1207
Target:  

Apoptosis

Research Areas:  

Cancer

Fexapotide (NX-1207) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research .
loading...
    loading...
Cat. No.: HY-P3501A
Synonyms: NX-1207 TFA
Target:  

Apoptosis

Research Areas:  

Cancer

Fexapotide (NX-1207) TFA induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research .
loading...
    loading...
Cat. No.: HY-10122R
CAS No.: 160970-54-7
Synonyms: KAD 3213 (Standard); KMD 3213 (Standard)
Silodosin (Standard) is the analytical standard of Silodosin. This product is intended for research and analytical applications. Silodosin (KAD 3213; KMD 3213) is a potent, selective and orally active α1A-adrenergic receptor (α1A-AR) blocker. Silodosin exhibits high affinity for α1A-AR (Ki=0.036 nM), over 162-fold and 50-fold than for α1B-AR and α1D-AR with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an effective and well-tolerated agent, it can be used for the investigation of LUTS/BPH .
loading...
    loading...
Cat. No.: HY-116379
CAS No.: 232953-52-5
Target:  

Adrenergic Receptor

Research Areas:  

Metabolic Disease

RS-100329 is an α1-adrenergic receptor (α1-AR) antagonist that effectively inhibits α1-adrenergic receptor-mediated contractions of lower urinary tract tissues in vitro and in vivo. RS-100329 can be used in the research of symptoms related to benign prostatic hyperplasia .
loading...
    loading...
Cat. No.: HY-116408
CAS No.: 60569-19-9
Target:  

mAChR

Research Areas:  

Neurological Disease

Propiverine is a potent antimuscarinic agent. Propiverine inhibits cellular calcium influx, thereby diminishing muscle spasm. Propiverine has neurotropic and musculotropic effects on the urinary bladder smooth muscle. Propiverine can used for overactive bladder (OAB) research .
loading...
    loading...
Cat. No.: HY-N20218
Category:  

Extract

Target:  

Others

Pumpkin seed extract is an extract from pumpkin (Cucurbita) that can be used to study lower urinary tract symptoms.
loading...
    loading...
Cat. No.: HY-N18683
CAS No.: 84604-15-9
Category:  

Extract

Target:  

Others

Saw palmetto extract can be used to study lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
loading...
    loading...
Cat. No.: HY-101008
CAS No.: 133399-65-2
3-MPPI is a GPCR ligand with high selectivity for α1-adrenergic receptor, with a Ki value of 0.21 nM for α1-adrenergic receptor and 50 nM for 5-HT1A receptor. 3-MPPI modulates the α1-adrenergic receptor signaling cascade. 3-MPPI is applicable to research related to hypertension, stress-induced anxiety-like behavioral responses, and levodopa-induced dyskinesia .
loading...
    loading...